Merck Unveils New Zilmax Safety Plan
Company Changes Label to Lower Dose, Plans In-Field Use Studies
Merck & Co. offered an update Wednesday on its push to improve the safety of its controversial livestock drug that was pulled from the U.S. market last year.
Subscriber-Only Content
To read the Full Story, upgrade your account to a FREE trial of MyDTN today.
- Exclusive access to comprehensive, customized insight anytime, anywhere
- If you're a Community user, all of your settings will transfer into your trial